A recent study has described a lower expression of GAL-3 in scleroderma lesional skin compared to normal controls, although the authors report a significant correlation between higher GAL-3 expression in fibroblasts from lesional skin of SSc patients and severe disease [26]. This evidence concerns the gene LGALS3 and scleroderma.